Sodium Nitroprusside (Akorn, Inc.)
Welcome to the PulseAid listing for the Sodium Nitroprusside drug offered from Akorn, Inc.. This Vasodilation [PE],Vasodilator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Sodium Nitroprusside |
SUBSTANCE NAME: | SODIUM NITROPRUSSIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vasodilation [PE],Vasodilator [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-05-04 |
END MARKETING DATE: | 0000-00-00 |
Sodium Nitroprusside HUMAN PRESCRIPTION DRUG Details:
Item Description | Sodium Nitroprusside from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/2mL) |
START MARKETING DATE: | 2017-05-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-014_03519ae4-0c72-4acf-a759-f992f7b10273 |
PRODUCT NDC: | 17478-014 |
APPLICATION NUMBER: | ANDA208635 |
Other SODIUM NITROPRUSSIDE Pharmaceutical Manufacturers / Labelers: